close
MENU
Hot Topic ELECTIONS
Hot Topic ELECTIONS
1 mins to read

Hellaby MD warned his company could become a takeover target

When Bapcor's $322.5 million takeover bid landed, Hellaby Holdings' managing director Alan Clarke had been on a road show telling people his company's share price was too low.

Jenny Ruth
Fri, 30 Sep 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.

Hellaby Holdings managing director Alan Clarke had already been telling brokers, analysts and investors the share price was under-valued even before Tuesday’s $322.5 million takeover offer from Australia-based Bapcor.

The shares have risen from as low as $2.45 in June to $3.32 on Thursday, above

Want to read more? It's easy.

Choose your subscription

Already have an account? Login

Smartphone Only Subscription

NZ$29.95 / monthly

Monthly Premium Online Subscription

NZ$49.95 / monthly

Smartphone Only Annual Subscription

NZ$299.00 / yearly

Yearly Premium Online Subscription

NZ$499.00 / yearly

Premium Group Membership 10 Users

NZ$385+GST / monthly

$38.5 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$660+GST / monthly

$33 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1375+GST / monthly

$27.5 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$2100+GST / monthly

$21 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$999.00 / yearly

Individual
Group membership
NBR Marketplace

Student

Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
Jenny Ruth
Fri, 30 Sep 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.

Free News Alerts

Sign up to get the latest stories and insights delivered to your inbox – free, every day.

I’m already subscribed/joined

Free News Alerts

Sign up to get the latest stories and insights delivered to your inbox – free, every day.

I’m already subscribed/joined
Hellaby MD warned his company could become a takeover target
62031
true